Fiche centre
Site Number - 9001
Belgrade — Serbia
Essais liés3clinical trials
VilleBelgradelocalisation
PaysSerbialocalisation
SourcelocaleCSV/MySQL
Informations
centreSynchronisé depuis ClinicalTrials.gov — NCT05403541
Essais cliniques associés
3| Molécule | Indication / population | Phase | NCT | Titre | Statut |
|---|---|---|---|---|---|
| IMVT-1402 | Lupus | Phase 2 | NCT06980805 | A Study to Assess the Safety, Tolerability, and Efficacy of IMVT-1402 in Participants With Cutaneous Lupus Erythematosus (CLE) | ACTIVE_NOT_RECRUITING |
| Batoclimab 680 mg SC weekly | Myasthénie | Phase 3 | NCT05403541 | Phase 3 Study to Assess the Efficacy and Safety of Batoclimab as Induction and Maintenance Therapy in Adult Participants With Generalized Myasthenia Gravis | TERMINATED |
| IMVT-1402 | Myasthénie | Phase 3 | NCT07039916 | Study to Assess the Efficacy and Safety of IMVT-1402 in Participants With Mild to Severe Generalized Myasthenia Gravis | RECRUITING |